20/20 Biolabs Inc
NASDAQ:AIDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
20/20 Biolabs Inc
NASDAQ:AIDX
|
US |
|
C
|
CellaVision AB
SWB:C26
|
SE |
|
D
|
DeNA Co Ltd
SWB:D2N
|
JP |
Bankruptcy Probability
20/20 Biolabs Inc's probability of bankruptcy is 3.6%, pointing to a small but noticeable default risk. The solvency score is 46/100 — a warning sign of potential financial weakness.
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
20/20 Biolabs Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
20/20 Biolabs Inc
NASDAQ:AIDX
|
6.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8.2T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
45.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
28.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Kainos Laboratories Inc
TSE:4556
|
4.2T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
102.4B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
6.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
1T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
20/20 Biolabs Inc's probability of bankruptcy is 50%, signalling a meaningful chance of default.
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, 20/20 Biolabs Inc has total debt of 694k . This includes both short-term (74.6k ) and long-term (619.4k ) debt.
You can find a full breakdown on its Balance Sheet.
